Beneficial effect of low-dose mianserin on fluvoxamine-induced akathisia in an obsessive-compulsive patient.

Abstract

Extrapyramidal side effects induced by some selective serotonin reuptake inhibitors (SSRIs), i.e. fluoxetine and sertraline, have been previously reported in patients with depression and obsessive-compulsive disorder (OCD). However, the occurrence and management of akathisia induced by fluvoxamine have not been described. In the presented case fluvoxamine-induced akathisia in an OCD patient was partially resistant to the anticholinergic agent biperiden, and was successfully treated with the 5-HT2A/5-HT2C antagonist mianserin. Mianserin (15 mg/day at 21.00 h) was discontinued and then reinstituted (off-on-off-on design). Biperiden was transiently effective in the acute akathisia, while the more persistent akathisia was alleviated by mianserin. Discontinuation of mianserin resulted in recurrence of akathisia, while full amelioration of the symptoms of akathisia was noted when mianserin was reinstituted. No aggravation of OCD symptoms was noted during mianserin administration.

• Authors: M Poyurovsky, I Meerovich, A Weizman
• Journal: International clinical psychopharmacology (Int Clin Psychopharmacol) Vol. 10 Issue 2 Pg. 111-4 (Jun 1995) ISSN: 0268-1315 [Print] England
• PMID: 7673653 (Publication Type: Case Reports, Journal Article)

Chemical References

• Biperiden
• Mianserin
• Fluvoxamine

Topics

• Adult
• Akathisia, Drug-Induced (drug therapy, etiology)
• Biperiden (pharmacology)
• Fluvoxamine (adverse effects, therapeutic use)
• Follow-Up Studies
• Humans
• Male
• Mianserin (therapeutic use)
• Obsessive-Compulsive Disorder (drug therapy)